Agreement between Estimated and Measured Renal Function in an Everyday Clinical Outpatient Setting of Human Immunodeficiency Virus-Infected Individuals

Nephron

Volumn 136, Issue 4, 2017, Pages 318-327

  Ahlström, Magnus Glindvad ^a   Kjær, Andreas ^a   Gerstoft, Jan ^a,b   Obel, Niels ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Glomerular filtration rate; Human immunodeficiency virus; Nephrotoxicity; Predicted creatinine clearance

Indexed keywords

COBICISTAT; CREATININE; DOLUTEGRAVIR; PROTEINASE INHIBITOR; RILPIVIRINE; TENOFOVIR DISOPROXIL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; REPRODUCIBILITY; UNIVERSITY HOSPITAL; VIRUS LOAD; BLOOD; COHORT ANALYSIS; DENMARK; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION TEST; MIDDLE AGED; OUTPATIENT; PATHOPHYSIOLOGY;

ADULT; ANTI-HIV AGENTS; COHORT STUDIES; CREATININE; DENMARK; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OUTPATIENTS; REPRODUCIBILITY OF RESULTS;

EID: 85018877808     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000469668     Document Type: Article

References (26)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 1998; 338: 853-860.
2. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, et al: Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146: 87-95.
3. Effersoe P: Relationship between endogenous 24-hour creatinine clearance and serum creatinine concentration in patients with chronic renal disease. Acta Med Scand 1957; 156: 429-434.
4. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
5. Levey AS, Bosch JP, Lewis JB, Greene T: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
6. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
7. Fleming JS, Wilkinson J, Oliver RM, Ackery DM, Blake GM, Waller DG: Comparison of radionuclide estimation of glomerular filtration rate using technetium 99m diethylenetriaminepentaacetic acid and chromium 51 ethylenediaminetetraacetic acid. Eur J Nucl Med 1991; 18: 391-395.
8. Brandstrom E, Grzegorczyk A, Jacobsson L, Friberg P, Lindahl A, Aurell M: GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant 1998; 13: 1176-1182.
9. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483.
10. Barraclough K, Er L, Ng F, Harris M, Montaner J, Levin A: A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract 2009; 111:c39-c48.
11. Bonjoch A, Bayes B, Riba J, Puig J, Estany C, Perez-Alvarez N, et al: Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort. Antiviral Res 2010; 88: 347-354.
12. Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, Hoek FJ, et al: A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clin Nephrol 2012; 77: 311-320.
13. Praditpornsilpa K, Avihingsanon A, Chaiwatanarat T, Chaiyahong P, Wongsabut J, Ubolyam S, et al: Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients. AIDS 2013; 26: 1781-1788.
14. Beringer PM, Owens H, Nguyen A, Mordwinkin N, Louie S, Mak M, et al: Estimation of glomerular filtration rate by using serum cystatin C and serum creatinine concentrations in patients with human immunodeficiency virus. Pharmacotherapy 2010; 30: 1004-1010.
15. Van Deventer HE, Paiker JE, Katz IJ, George JA: A comparison of cystatin C-and creatinine-based prediction equations for the estimation of glomerular filtration rate in black South Africans. Nephrol Dial Transplant 2011; 26: 1553-1558.
16. Gagneux-Brunon A, Delanaye P, Maillard N, Fresard A, Basset T, Alamartine E, et al: Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS 2013; 27: 1573-1581.
17. Omland LH, Ahlstrom MG, Obel N: Cohort profile update: The Danish HIV cohort study (DHCS). Int J Epidemiol 2014; 43: 1769-1769e.
18. Obel N, Engsig FN, Rasmussen LD, Larsen M V, Omland LH, Sorensen HT: Cohort profile: The Danish HIV cohort study. Int J Epidemiol 2009; 38: 1202-1206.
19. Bjornsson TD, Cocchetto DM, McGowan FX, Verghese CP, Sedor F: Nomogram for estimating creatinine clearance. Clin Pharmacokinet 1983; 8: 365-369.
20. Mawer GE, Lucas SB, Knowles BR, Stirland RM: Computer-assisted prescribing of kanamycin for patients with renal insufficiency. Lancet 1972; 1: 12-15.
21. Hull JH, Hak LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM: Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 1981; 29: 516-521.
22. Gates GF: Creatinine clearance estimation from serum creatinine values: An analysis of three mathematical models of glomerular function. Am J Kidney Dis 1985; 5: 199-205.
23. Jelliffe RW: Estimation of creatinine clearance when urine cannot be collected. Lancet 1971; 1: 975-976.
24. Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, Carrara F, et al: The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013; 84: 164-173.
25. Lin LI: A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-268.
26. Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, et al: Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: Two randomised, double-blind, phase 3, non-inferiority trials. Lancet 2015; 385: 2606-2615.